RGS17 antibody
Quick Overview for RGS17 antibody (ABIN7118379)
Target
See all RGS17 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Purpose
- RGS17 antibody
-
Purification
- Immunogen affinity purified
-
Purity
- ≥95 % as determined by SDS-PAGE
-
Immunogen
- regulator of G-protein signaling 17
-
Isotype
- IgG
-
-
-
-
Application Notes
- WB: 1:500-1:2000, IHC: 1:20-1:200, IF: 1:20-1:200
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide and 50 % glycerol pH 7.3,
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid repeated freeze / thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- -20°C for 12 months
-
Expiry Date
- 12 months
-
-
- RGS17 (Regulator of G-Protein Signaling 17 (RGS17))
-
Alternative Name
- RGS17
-
Background
-
Synonyms: Regulator of G-protein signaling 17 (RGS17)|RGS17|RGSZ2
Background: Regulates G protein-coupled receptor signaling cascades, including signaling via muscarinic acetylcholine receptor CHRM2 and dopamine receptor DRD2. Inhibits signal transduction by increasing the GTPase activity of G protein alpha subunits, thereby driving them into their inactive GDP-bound form(PubMed:15096504). Binds selectively to GNAZ and GNAI2 subunits, accelerates their GTPase activity and regulates their signaling activities. Negatively regulates mu-opioid receptor-mediated activation of the G-proteins(By similarity).
-
Molecular Weight
- 27 kDa
-
Gene ID
- 26575
-
UniProt
- Q9UGC6
-
Pathways
- Myometrial Relaxation and Contraction, Regulation of G-Protein Coupled Receptor Protein Signaling
Target
-